Target intelligence / Profile preview

α-Lactalbumin (Alpha-lactalbumin) (LALBA)

Target
LALBA
Molecular classification
Protein, Calcium-binding protein, Regulatory subunit (of lactose synthase), Member of the Lysozyme/α-lactalbumin protein superfamily
01

Overview

α-Lactalbumin is a small (14 kDa), acidic, calcium-binding protein found in the whey fraction of milk across all mammals. It is encoded by the LALBA gene and forms the regulatory subunit of lactose synthase, the enzyme complex responsible for lactose production in the mammary gland. The protein modulates the specificity of β-1,4-galactosyltransferase, dramatically enhancing its affinity for glucose and enabling the synthesis of lactose. Structurally, α-lactalbumin consists of 123 amino acids, 4 disulfide bridges, and has a single strong calcium-binding site that imparts stability and unique folding properties. Certain modified forms of α-lactalbumin, such as HAMLET (human α-lactalbumin made lethal to tumor cells), have been shown to induce apoptosis in cancer cells and possess bactericidal function, suggesting possible roles in cancer and infection research. Despite these interesting biological effects, α-lactalbumin is not considered a classic drug target like receptors or enzymes.

Other names
Alpha-lactalbuminLALBAwhey protein (in the context of milk protein composition)
02

Mechanism of action

not a therapeutic target for drugs, but as HAMLET, induces apoptosis via cell membrane disruption and delivery of cytotoxic fatty acids to tumor cells

03

Biological functions

Lactose biosynthesis (regulation of lactose synthase activity)Calcium bindingPotential antimicrobial and antitumor activities in specific formations (e.g., HAMLET complex)Modulation of enzymatic specificity
04

Disease associations

Cancer (HAMLET complex—induces apoptosis in tumor cells)Infection (antibacterial activity, especially in complexed forms)Other (potential applications in drug delivery)
05

Safety considerations

generally regarded as safe for consumption; possible immunogenicity/allergy in susceptible individuals; HAMLET complex cytotoxicity may have off-target effects

Beyond the preview

Go deeper on α-Lactalbumin (Alpha-lactalbumin) (LALBA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on α-Lactalbumin (Alpha-lactalbumin) (LALBA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call